Positive Airway Pressure Devices Market Summary

The global positive airway pressure devices market size was estimated at USD 2.48 billion in 2024 and is projected to reach USD 4.04 billion by 2033, growing at a CAGR of 5.60% from 2025 to 2033. This growth is attributed to the increasing prevalence of sleep apnea, ongoing advancements in PAP device technology, rising awareness of sleep-related disorders, and consistent improvements in healthcare infrastructure across both developed and emerging economies. As diagnostic capabilities advance, more individuals are being identified with sleep disorders, driving the need for reliable and user-friendly treatment solutions such as CPAP, BiPAP, and APAP devices.

These factors are fueling the demand for PAP devices globally. Growing health concerns, better diagnostic methods, and technological innovations are collectively strengthening the market’s growth outlook. Obstructive sleep apnea is a common respiratory condition characterized by disrupted breathing patterns and reduced oxygen supply to the brain. According to estimates published in 2023 by the Saudi Journal of Otorhinolaryngology-Head and Neck Surgery on the global prevalence of obstructive sleep apnea, approximately 936 million people suffer from mild to severe sleep apnea, with around 425 million individuals aged 30 to 69 experiencing moderate-to-severe forms. Rapid globalization, lifestyle modifications, and unhealthy dietary habits are contributing significantly to the rising prevalence of this disorder. Additionally, increasing obesity rates and sedentary behavior are key factors driving the incidence of obstructive sleep apnea worldwide.

Key Market Trends & Insights

• North America dominated the global market for positive airway pressure devices with a revenue share of 46.8% in 2024, supported by advanced healthcare systems, high diagnosis rates, and widespread adoption of home sleep therapy devices.
• The positive airway pressure devices industry in the U.S. has seen significant growth over the forecast period due to the rising prevalence of respiratory diseases such as obstructive sleep apnea and increasing awareness regarding the availability and effectiveness of PAP-based treatment options.
• By application, the obstructive sleep apnea segment led the market in 2024, reflecting strong global demand for effective therapies to treat this widely prevalent condition.
• By end use, the hospitals and clinics segment was the leading segment in 2024 and accounted for the largest market share, driven by the availability of specialized diagnostic equipment and professional clinical support.

Order a free sample PDF of the Positive Airway Pressure Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 2.48 Billion
• 2033 Projected Market Size: USD 4.04 Billion
• CAGR (2025-2033): 5.60%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Key players focus on product innovation, incorporating features such as enhanced comfort, noise reduction, portability, and connectivity with mobile apps for remote monitoring. In addition, strategic collaborations, acquisitions, and regional expansions help maintain a strong foothold in developed and emerging markets. For instance, in February 2021, Philips and the Dutch SAZ group entered a strategic partnership to offer a complete suite of monitoring, observation, and self-management services to patients diagnosed with obstructive sleep apnea. The market is characterized by increasing investments in research and development to improve PAP devices' efficacy and user experience.

Key Players

• Koninklijke Philips N.V.
• SEFAM
• Trudell Medical (Vyaire)
• Löwenstein Medical UK Ltd
• Transcend Inc. (Somnetics International, Inc.)
• Fisher & Paykel Healthcare Limited
• ResMed
• Drive DeVilbiss Healthcare
• React Health (3B Medical)
• BMC Medical
• Armstrong Medical Inc.
• Wellell (Apex Medical)
• Breas Medical

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

Overall, the positive airway pressure devices market is poised for sustained growth as sleep disorders continue to rise globally and healthcare systems improve their diagnostic capabilities. Increasing awareness of the long-term health risks associated with untreated sleep apnea is encouraging more patients to seek timely treatment, further supporting market expansion. Technological advancements, including quieter devices, improved mask designs, and enhanced data connectivity, are also increasing user comfort and compliance. With strong demand across North America and emerging opportunities in developing regions, PAP devices are expected to remain essential tools in the management of sleep-related respiratory conditions in the coming years.